- Home
- LMND vs SWTX Comparison
LMND vs SWTX Comparison
Compare LMND & SWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMND
- SWTX
- Stock Information
- Founded
- LMND 2015
- SWTX 2017
- Country
- LMND United States
- SWTX United States
- Employees
- LMND N/A
- SWTX N/A
- Industry
- LMND Property-Casualty Insurers
- SWTX Biotechnology: Pharmaceutical Preparations
- Sector
- LMND Finance
- SWTX Health Care
- Exchange
- LMND Nasdaq
- SWTX Nasdaq
- Market Cap
- LMND 2.0B
- SWTX 2.2B
- IPO Year
- LMND 2020
- SWTX 2019
- Fundamental
- Price
- LMND $49.29
- SWTX $39.02
- Analyst Decision
- LMND Hold
- SWTX Strong Buy
- Analyst Count
- LMND 8
- SWTX 6
- Target Price
- LMND $33.71
- SWTX $64.50
- AVG Volume (30 Days)
- LMND 3.8M
- SWTX 1.4M
- Earning Date
- LMND 10-30-2024
- SWTX 11-12-2024
- Dividend Yield
- LMND N/A
- SWTX N/A
- EPS Growth
- LMND N/A
- SWTX N/A
- EPS
- LMND N/A
- SWTX N/A
- Revenue
- LMND $492,500,000.00
- SWTX $135,487,000.00
- Revenue This Year
- LMND N/A
- SWTX $3,498.68
- Revenue Next Year
- LMND $26.74
- SWTX $98.08
- P/E Ratio
- LMND N/A
- SWTX N/A
- Revenue Growth
- LMND 22.09
- SWTX N/A
- 52 Week Low
- LMND $14.03
- SWTX $20.19
- 52 Week High
- LMND $52.22
- SWTX $53.92
- Technical
- Relative Strength Index (RSI)
- LMND 85.02
- SWTX 67.93
- Support Level
- LMND $31.41
- SWTX $36.13
- Resistance Level
- LMND $52.22
- SWTX $38.58
- Average True Range (ATR)
- LMND 3.57
- SWTX 2.38
- MACD
- LMND 2.06
- SWTX 0.61
- Stochastic Oscillator
- LMND 89.80
- SWTX 94.15
About LMND Lemonade Inc.
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. Geographically, it operates in California, Texas, New York, New Jersey, Illinois, Georgia, Washington, Colorado, Pennsylvania, Oregon and others.
About SWTX SpringWorks Therapeutics Inc.
SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.